Autologous Cellular Graft in Surgical Treatment of Vitiligo
Megadott ok: lack of availability of the needed kits
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálat adatai
- Ki végzi
- Cairo University
- Azonosító
- NCT05503368
- A regiszteradat frissítve
- 2023. január 25.
- Eredeti leírás
This is a double blinded self controlled randomized trial to assess Autologous Micro Cellular Grafts in surgical treatment of stable resistant vitiligo. Given the stem cells, progenitor cells, and growth factors rich hair follicle based suspension resulting from Autologous Cellular Micro grafts (ACM), we aim at assessing the efficacy of ACM generated suspension in comparison to follicle cell suspension in surgical treatment of stable resistant vitiligo.A teljes eredeti leírásKevesebb
Autologous Cellular Micro-graft in Surgical Treatment of Stable Resistant Vitiligo: A Randomized Self-controlled Trial
This is a double blinded self controlled randomized trial to assess Autologous Micro Cellular Grafts in surgical treatment of stable resistant vitiligo. Given the stem cells, progenitor cells, and growth factors rich hair follicle based suspension resulting from Autologous Cellular Micro grafts (ACM), we aim at assessing the efficacy of ACM generated suspension in comparison to follicle cell suspension in surgical treatment of stable resistant vitiligo.
Bevonási feltételek: Patients with non-segmental vitiligo (NSV) / segmental resistant lesions; with either 2 comparable lesions or large patches that can be divided; Stability for ≥ 1 year; Age >18 years; Lack of treatment for at least 1 month prior to surgery.
Kizáró feltételek: Bleeding tendency; Age < 18 years; -Vitiligo lesions responsive to conventional treatment modalities; Active vitiligo; new lesions, expansion of old lesions or koebnerization in < 1 year; Keloidal tendency; Pregnant females.